Methodist Health System COVID-19 Patient Registry
NCT04477889 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 550
Last updated 2026-05-19
Summary
This is a prospective cohort observational registry study that will include data on all patients who are treated at MHS facilities for COVID-19.
Conditions
Interventions
- OTHER
-
Treatment for COVID-19
Patients treated for COVID-19
Sponsors & Collaborators
-
Methodist Health System
lead OTHER
Principal Investigators
-
Crystee Cooper, DHEd · Methodist Health System
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-20
- Primary Completion
- 2025-06-16
- Completion
- 2025-06-16
Countries
- United States
Study Locations
More Related Trials
-
Ain Shams University Experience: Clinical Determinants of Hospitalized COVID-19 Patients
NCT04584606 ·Status: UNKNOWN
-
Convalescent Plasma for Patients With COVID-19
NCT04385199 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Molnupiravir (MK-4482) in Non-Hospitalized Adult Participants With COVID-19 (MK-4482-002)
NCT04575597 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b
NCT02845843 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
MP0420 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
NCT05780463 ·Status: COMPLETED ·Phase: PHASE3
-
The Safety of Molnupiravir (EIDD-2801) and Its Effect on Viral Shedding of SARS-CoV-2 (END-COVID)
NCT04405739 ·Status: COMPLETED ·Phase: PHASE2
-
Collection of Anti-SARS-CoV-2 Immune Plasma
NCT04344977 ·Status: COMPLETED
-
Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients
NCT04321993 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate the Clinical Outcomes in Adults With Covid-19 Who Have Been Treated With Remdesivir.
NCT04847622 ·Status: COMPLETED
-
Registry of COVID-19 Patients Treated With the Seraph 100 Microbind Affinity Blood Filter
NCT04361500 ·Status: UNKNOWN
-
CoVID-19 Plasma in Treatment of COVID-19 Patients
NCT04355897 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older
NCT04405076 ·Status: COMPLETED ·Phase: PHASE2
-
Remdesivir in Adults With Covid-19: Mansoura University Hospital Experience
NCT04728880 ·Status: UNKNOWN
-
Use of Convalescent Plasma for COVID-19
NCT04408040 ·Status: TERMINATED ·Phase: PHASE2
-
COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose
NCT05392075 ·Status: COMPLETED
-
A Real-world Retrospective Study of Disease Outcomes in Non-severe COVID-19 Patient
NCT05489874 ·Status: UNKNOWN
-
COVID-OUT: Early Outpatient Treatment for SARS-CoV-2 Infection (COVID-19)
NCT04510194 ·Status: COMPLETED ·Phase: PHASE3
-
Multicenter, Retrospective Study of the Effects of Remdesivir in the Treatment of Severe Covid-19 Infections
NCT04365725 ·Status: COMPLETED
-
An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness
NCT05381454 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection
NCT04392232 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.
NCT05911906 ·Status: COMPLETED ·Phase: PHASE4
-
LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
NCT05077332 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized Patients
NCT04354831 ·Status: COMPLETED ·Phase: PHASE2
-
A Real World Study of Paxlovid for the Treatment of Hospitalized Patients Confirmed With COVID-19
NCT05387369 ·Status: RECRUITING
-
Singapore SARS-CoV-2 Human Challenge Study
NCT06654973 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA